WallStreetZenWallStreetZen

NASDAQ: GDRX
Goodrx Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for GDRX

Based on 13 analysts offering 12 month price targets for Goodrx Holdings Inc.
Min Forecast
$5.00-13.79%
Avg Forecast
$7.96+37.28%
Max Forecast
$12.00+106.9%

Should I buy or sell GDRX stock?

Based on 13 analysts offering ratings for Goodrx Holdings Inc.
Buy
Strong Buy
3 analysts 23.08%
Buy
1 analysts 7.69%
Hold
9 analysts 69.23%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GDRX stock forecasts and price targets.

GDRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-17
lockedlocked$00.00+00.00%2023-11-13
lockedlocked$00.00+00.00%2023-11-10
lockedlocked$00.00+00.00%2023-11-10
lockedlocked$00.00+00.00%2023-11-10
Deutsche Bank
Top 9%
92
HoldMaintains$8.00+37.93%2023-08-10
Guggenheim
Top 8%
93
Strong BuyMaintains$10.00+72.41%2023-08-10
Citigroup
Top 21%
80
Strong BuyMaintains$11.00+89.66%2023-08-10
Evercore ISI Group
Top 1%
100
HoldMaintains$10.00+72.41%2023-08-10
Credit Suisse
Bottom 9%
9
HoldMaintains$8.00+37.93%2023-08-10

1 of 2

Forecast return on equity

Is GDRX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
30.07%

Forecast return on assets

Is GDRX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

GDRX revenue forecast

What is GDRX's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$748.4M+1.44%
Avg 2 year Forecast
$782.2M+6.03%
Avg 3 year Forecast
$828.0M+12.23%
GDRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GDRX earnings growth forecast

How is GDRX forecast to perform vs Health Information Services companies and vs the US market?
Company
110.55%
Industry
27.73%
Market
17.91%
GDRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GDRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GDRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GDRX revenue growth forecast

How is GDRX forecast to perform vs Health Information Services companies and vs the US market?
Company
3.83%
Industry
11.57%
Market
7.54%
GDRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GDRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GDRX vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
GDRX$5.80$7.96+37.28%Buy
CERT$14.54$55.50+281.71%Buy
SDGR$31.46$59.00+87.54%Buy
PINC$20.53$25.88+26.04%Hold
PRVA$21.15$36.00+70.21%Strong Buy
View Top Health Information Service Stocks

Goodrx Holdings Stock Forecast FAQ

Is Goodrx Holdings Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NASDAQ: GDRX) stock is to Buy GDRX stock.

Out of 13 analysts, 3 (23.08%) are recommending GDRX as a Strong Buy, 1 (7.69%) are recommending GDRX as a Buy, 9 (69.23%) are recommending GDRX as a Hold, 0 (0%) are recommending GDRX as a Sell, and 0 (0%) are recommending GDRX as a Strong Sell.

If you're new to stock investing, here's how to buy Goodrx Holdings stock.

What is GDRX's revenue growth forecast for 2023-2025?

(NASDAQ: GDRX) Goodrx Holdings's forecast annual revenue growth rate of 3.83% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 11.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.54%.

Goodrx Holdings's revenue in 2023 is $737,730,000.On average, 8 Wall Street analysts forecast GDRX's revenue for 2023 to be $303,935,753,516, with the lowest GDRX revenue forecast at $301,999,722,482, and the highest GDRX revenue forecast at $306,974,838,943. On average, 8 Wall Street analysts forecast GDRX's revenue for 2024 to be $317,684,944,754, with the lowest GDRX revenue forecast at $314,342,072,624, and the highest GDRX revenue forecast at $330,018,766,126.

In 2025, GDRX is forecast to generate $336,259,795,894 in revenue, with the lowest revenue forecast at $326,002,121,081 and the highest revenue forecast at $345,455,841,774.

What is GDRX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: GDRX) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of N/A.

What is GDRX's Price Target?

According to 13 Wall Street analysts that have issued a 1 year GDRX price target, the average GDRX price target is $7.96, with the highest GDRX stock price forecast at $12.00 and the lowest GDRX stock price forecast at $5.00.

On average, Wall Street analysts predict that Goodrx Holdings's share price could reach $7.96 by Nov 17, 2024. The average Goodrx Holdings stock price prediction forecasts a potential upside of 37.28% from the current GDRX share price of $5.80.

What is GDRX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: GDRX) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.